35065-86-2Relevant articles and documents
-
Smith,Haller
, p. 143 (1939)
-
INHIBITORS OF HEPATITIS C VIRUS REPLICATION
-
Paragraph 0888-0889, (2019/05/15)
The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
Protection of COOH and OH groups in acid, base and salt free reactions
Zhu, Xiaotao,Qian, Bo,Wei, Rongbiao,Huang, Jian-Dong,Bao, Hongli
supporting information, p. 1444 - 1447 (2018/04/12)
We report an iron-catalyzed general functional group protection method with inexpensive reagents. This environmentally benign process does not use acids or bases, and does not produce waste products. Further purification beyond filtration and evaporation is, in most cases, unnecessary. Free COOH and OH groups can be protected in a one-pot reaction.